Edition:
United Kingdom

People: Diplomat Pharmacy Inc (DPLO.N)

DPLO.N on New York Stock Exchange

5.41USD
18 Apr 2019
Change (% chg)

$0.20 (+3.84%)
Prev Close
$5.21
Open
$5.21
Day's High
$5.44
Day's Low
$5.21
Volume
152,026
Avg. Vol
258,880
52-wk High
$28.74
52-wk Low
$4.99

Benjamin, Regina 

Dr. Regina M. Benjamin, M.D., MBA serves as Independent Director of the Company. Dr. Benjamin is Former United States Surgeon General and a practicing family physician. In July 2009, Dr. Benjamin was appointed as the 18th United States Surgeon General and served a four-year term. During such period, Dr. Benjamin served as the Chair of the National Prevention, Health Promotion, and Public Health Council, which consists of 17 cabinet-level Federal agencies that released the first ever National Prevention Strategy, a roadmap for health. In addition, since September 2013, Dr. Benjamin has served as the NOLA.com/Times Picayune Endowed Chair in Public Health Sciences at Xavier University of Louisiana. Dr. Benjamin is the founder and Chief Executive Officer of BayouClinic, Inc., a Federally Qualified Health Center Look-Alike clinic in Alabama which Dr. Benjamin founded in 1990. From December 2013 through July 2015, Dr. Benjamin served on the board of directors of Alere Inc. (NYSE:ALR), a healthcare diagnostics company, where she served on the nominating and corporate governance committee. Dr. Benjamin also currently serves on boards of directors of Kaiser Foundation Hospitals and Health Plan since 2015, as well as Ascension healthcare system. She serves on the following public companies in addition to Diplomat: ConvaTec Group, PLC and Computer Programs and Systems, Inc. (Nasdaq: CPSI) where she serves on the nominating and corporate governance committee. Dr. Benjamin also serves on the national board of the March of Dimes.

Basic Compensation

Total Annual Compensation, USD --
Restricted Stock Award, USD 98,503
Long-Term Incentive Plans, USD --
All Other, USD 56,250
Fiscal Year Total, USD 154,753

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --